Feed GXAI
GX

Gaxos.ai Inc.

GXAI · NASDAQ

$0.42 -6.80% (-$0.03)
1M -42.39%
Market Cap $4.33M
P/E Ratio -
Div. Yield -
ROE 25.74%
Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Weak
2/9
Valuation
100 /100
Cheap
P/B 0.25x
P/S 0.72x
EV/EBITDA N/A
Growth
100 /100
Growing
Book val. growth 167.52%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak
Net margin 64.79%
Op. margin 115.80%
FCF margin 90.91%
Quality
5 /100
Poor
ROE 25.74%
ROA 22.28%
Asset turnover 0.34x
Debt
100 /100
Low
Current ratio 10.57x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
37 /100
Moderate
EPS volatility 141.99%
Profitable years 0
Beta 0.82x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about GXAI
Online

About the company

Gaxos.ai Inc. (GAXS) is an American technology company specializing in artificial intelligence and machine learning applications in healthcare. With a focus on innovation in diagnostics and personalized medicine, Gaxos.ai is a leader in using advanced algorithms to analyze health data and support medical decision-making. The company develops intelligent systems and applications that enhance the efficiency and accuracy of diagnoses, thereby positively impacting patient care. Gaxos.ai also collaborates with research institutions and healthcare organizations to advance new technologies in health informatics. Gaxos.ai Inc. (GAXS) shares could be suitable for investors looking to invest in technological innovations in healthcare with potential to improve the quality of healthcare.

Sector

Technology

Industry

Electronic Gaming & Multimedia

CEO

Vadim Mats

Employees

3

Headquarters

Roseland

Upcoming events

12 NOV

Earnings

Upcoming earnings report

34d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.